Advisors


W. Scott Burgin, M.D.

W. Scott Burgin, M.D.

Clinical Advisor

Dr. Burgin is a Professor and Chief of Vascular Neurology at the University of South Florida Morsani College of Medicine.  His research interests include translational research in the area of cerebrovascular diseases.

Undergraduate– B.S. Psychology/Neuroscience, Duke University
Medical School– M.D. University of North Carolina- Chapel Hill
Internship– University of Rochester Department of Medicine
Residency– University of Rochester Department of Neurology
Cerebrovascular Fellowship– University of Texas- Houston

Publications include:

1: Ren Z, Mokin M, Bauer CT, Miao Z, Burgin WS, Wang Y. Indications for Mechanical Thrombectomy Too Wide or Too Narrow? World Neurosurg. 2019 Apr 19. pii: S1878-8750(19)31110-6. doi: 10.1016/j.wneu.2019.04.116. [Epub ahead of print] Review. PubMed PMID: 31009772.

2: Asdaghi N, Wang K, Ciliberti-Vargas MA, Gutierrez CM, Koch S, Gardener H, Dong C, Rose DZ, Garcia EJ, Burgin WS, Zevallos JC, Rundek T, Sacco RL, Romano JG; FL-PR CReSD Investigators and Collaborators. Predictors of Thrombolysis Administration in Mild Stroke: Florida-Puerto Rico Collaboration to Reduce Stroke Disparities. Stroke. 2018 Mar;49(3):638-645. doi: 10.1161/STROKEAHA.117.019341. Epub 2018 Feb 19. PubMed PMID: 29459397; PubMed Central PMCID: PMC5829011.

3: Mokin M, Pendurthi A, Ljubimov V, Burgin WS, Siddiqui AH, Levy EI, Primiani CT. ASPECTS, Large Vessel Occlusion and Time of Symptom Onset: Estimation of Eligibility for Endovascular Therapy. Neurosurgery. 2018 Jul 1;83(1):122-127. doi: 10.1093/neuros/nyx352. PubMed PMID: 29106687.

  • Sacco RL, Gardener H, Wang K, Dong C, Ciliberti-Vargas MA, Gutierrez CM, Asdaghi N, Burgin WS, Carrasquillo O, Garcia-Rivera EJ, Nobo U, Oluwole S, Rose DZ, Waters MF, Zevallos JC, Robichaux M, Waddy SP, Romano JG, Rundek T. Racial-Ethnic Disparities in Acute Stroke Care in the Florida-Puerto Rico Collaboration to Reduce Stroke Disparities Study.Journal of the American Heart Association. 6(2) , 2017. http://www.ncbi.nlm.nih.gov/pubmed/28196814
    • Martin RC, Burgin WS, Schabath MB, Kirby B, Chae SH, Fradley MG, Rose DZ, Labovitz AJ. Gender-Specific Differences for Risk of Disability and Death in Atrial Fibrillation-Related Stroke. The American journal of cardiology. 119(2) : 256-261, 2017. http://www.ncbi.nlm.nih.gov/pubmed/27846983
  • Burnside RD, Harris A, Speyer D, Burgin WS, Rose DZ, Sanchez-Valle A. Constitutional Chromoanagenesis of Distal 13q in a Young Adult with Recurrent Strokes.Cytogenetic and genome research. 150(1) : 46-51, 2016. http://www.ncbi.nlm.nih.gov/pubmed/27825145
    • Asdaghi N, Romano JG, Wang K, Ciliberti-Vargas MA, Koch S, Gardener H, Dong C, Rose DZ, Waddy SP, Robichaux M, Garcia EJ, Gonzalez-Sanchez JA, Burgin WS, Sacco RL, Rundek T. Sex Disparities in Ischemic Stroke Care: FL-PR CReSD Study (Florida-Puerto Rico Collaboration to Reduce Stroke Disparities). Stroke; a journal of cerebral circulation. , 2016. http://www.ncbi.nlm.nih.gov/pubmed/27553032
    • Mokin M, Gupta R, Guerrero WR, Rose DZ, Burgin WS, Sivakanthan S. ASPECTS decay during inter-facility transfer in patients with large vessel occlusion strokes. Journal of neurointerventional surgery. 9(5) : 442-444, 2017. http://www.ncbi.nlm.nih.gov/pubmed/27106593
  • Rose DZ, Guerrero WR, Mokin MV, Gooch CL, Bozeman AC, Pearson JM, Burgin WS. Hemorrhagic stroke following use of the synthetic marijuana “spice”. Neurology. 85(13) : 1177-9, 2015. http://www.ncbi.nlm.nih.gov/pubmed/26320200
  • Freeman MJ, Rose DZ, Myers MA, Gooch CL, Bozeman AC, Burgin WS. Ischemic stroke after use of the synthetic marijuana “spice”. Neurology. 81(24) : 2090-3, 2013. http://www.ncbi.nlm.nih.gov/pubmed/24212384
  • Leker RR, Molina C, Cockroft K, Liebeskind DS, Concha M, Shuaib A, De Deyn PP, Burgin WS, Gupta R, Dillon W, Diener HC. Effects of age on outcome in the SENTIS trial: better outcomes in elderly patients. Cerebrovasc Dis. 34(4) : 263-71, 2012. 
  • Hammer MD, Schwamm L, Starkman S, Schellinger PD, Jovin T, Nogueira R, Burgin WS, Sen S, Diener HC, Watson T, Michel P, Shuaib A, Dillon W, Liebesk. Safety and feasibility of NeuroFlo use in eight- to 24-hour ischemic stroke patients. Int J Stroke. 7(8) : 655-61, 2012. 
  • Athilingam P King KB Burgin WS Ackerman M Cushman LA Chen L. Montreal Cognitive Assessment and Mini-Mental Status Examination compared as cognitive screening tools in heart failure. Heart Lung.. 40(6) : 521-9, 2011. 
  • Young KC, Holloway RG, Burgin WS, Benesch CG. A cost-effectiveness analysis of carotid artery stenting compared with endarterectomy. Journal of Stroke and Cerebrovascular diseases : the official journal of National Stroke Association. 19(5) : 404-9, 2010. http://www.ncbi.nlm.nih.gov/pubmed/20816349
  • 18: Huxlin KR, Martin T, Kelly K, Riley M, Friedman DI, Burgin WS, Hayhoe M. Perceptual relearning of complex visual motion after V1 damage in humans. J Neurosci. 2009 Apr 1;29(13):3981-91. doi: 10.1523/JNEUROSCI.4882-08.2009. PubMed  PMID: 19339594; PubMed Central PMCID: PMC2825043.

BOARD OF DIRECTORS:

Maha Sallam, Ph.D.

Founder and President of VuEssence

Lorne Thomas, CFA

Lorne is the Managing Director at Athena Partners

Virginia (Ginny) Cates, CPA

Ginny is a CPA with over 35 years of experience